BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for Biomedical System Design - ECPv5.16.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center for Biomedical System Design
X-ORIGINAL-URL:https://newdigs.tuftsmedicalcenter.org
X-WR-CALDESC:Events for Center for Biomedical System Design
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20120101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20120913T000000
DTEND;TZID=UTC:20120914T000000
DTSTAMP:20260430T114025
CREATED:20180928T144958Z
LAST-MODIFIED:20180928T144958Z
UID:507-1347494400-1347580800@newdigs.tuftsmedicalcenter.org
SUMMARY:3rd DIA Health Technology Assessment (HTA) Forum
DESCRIPTION:Regulatory and HTA Interface Developments; “Ensuring Patient Access to Innovative Medicines through MIT NEWDIGS: A multi-stakeholder initiative to catalyse the evolution of adaptive licensing”Speaker: Dr. Tony Hoos (GlaxoSmithKline)
URL:https://newdigs.tuftsmedicalcenter.org/event/3rd-dia-health-technology-assessment-hta-forum/
CATEGORIES:Presentation
END:VEVENT
END:VCALENDAR